Publication | Closed Access

Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials

VaccinationVaccine SafetyCervical Intraepithelial NeoplasiaCervical Cancer ScreeningCancer-associated VirusCervical CancerCervical HealthHuman Papillomavirus VaccinesMedicineRandomised Clinical TrialsVaccine EfficacyCombined AnalysisPublic HealthOncologyRadiation OncologyPrecancerous LesionsCervical Cancer Prevention